Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Moreno

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
American Journal of Physiology. Renal Physiology|November 24, 2005
Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive ratsBernardo López, Robert P Ryan, Carol Moreno, et al.
Genes, Chromosomes & Cancer|August 26, 2010
Identification of novel carcinogen-mediated mammary tumor susceptibility loci in the rat using the chromosome substitution techniqueTatjana Adamovic, Donna McAllister, Tao Wang, et al.
Physiological Genomics|June 15, 2007
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive ratCarol Moreno, Mary L Kaldunski, Tao Wang, et al.
Blood|July 13, 2018
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapiesPeter Dreger, Paolo Ghia, Johannes Schetelig, et al.
Physiological Genomics|June 7, 2012
Role of genetic modifiers in an orthologous rat model of ARPKDCaitlin C O'Meara, Matthew Hoffman, William E Sweeney, et al.
Drug Discovery Today|May 21, 2018
Renal Pre-Competitive Consortium (RPC<sup>2</sup>): discovering therapeutic targets togetherMark Tomilo, Heather Ascani, Barbara Mirel, et al.
British Journal of Haematology|December 5, 2021
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trialsJohn N Allan, Tait Shanafelt, Adrian Wiestner, et al.
Leukemia & Lymphoma|June 29, 2011
Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemiaGerardo Ferrer, Kate Hodgson, Arturo Pereira, et al.
Cytometry. Part B, Clinical Cytometry|October 18, 2018
CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemiaAlba Mora, Rosa Bosch, Carolina Cuellar, et al.
Anesthesiology|October 25, 2011
Pharmacogenomic strain differences in cardiovascular sensitivity to propofolThomas A Stekiel, Stephen J Contney, Richard J Roman, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
American Journal of Physiology. Renal Physiology|November 24, 2005
Identification of a QTL on chromosome 1 for impaired autoregulation of RBF in fawn-hooded hypertensive ratsBernardo López, Robert P Ryan, Carol Moreno, et al.
Genes, Chromosomes & Cancer|August 26, 2010
Identification of novel carcinogen-mediated mammary tumor susceptibility loci in the rat using the chromosome substitution techniqueTatjana Adamovic, Donna McAllister, Tao Wang, et al.
Physiological Genomics|June 15, 2007
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive ratCarol Moreno, Mary L Kaldunski, Tao Wang, et al.
Blood|July 13, 2018
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapiesPeter Dreger, Paolo Ghia, Johannes Schetelig, et al.
Physiological Genomics|June 7, 2012
Role of genetic modifiers in an orthologous rat model of ARPKDCaitlin C O'Meara, Matthew Hoffman, William E Sweeney, et al.
Drug Discovery Today|May 21, 2018
Renal Pre-Competitive Consortium (RPC<sup>2</sup>): discovering therapeutic targets togetherMark Tomilo, Heather Ascani, Barbara Mirel, et al.
British Journal of Haematology|December 5, 2021
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trialsJohn N Allan, Tait Shanafelt, Adrian Wiestner, et al.
Leukemia & Lymphoma|June 29, 2011
Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemiaGerardo Ferrer, Kate Hodgson, Arturo Pereira, et al.
Cytometry. Part B, Clinical Cytometry|October 18, 2018
CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemiaAlba Mora, Rosa Bosch, Carolina Cuellar, et al.
Anesthesiology|October 25, 2011
Pharmacogenomic strain differences in cardiovascular sensitivity to propofolThomas A Stekiel, Stephen J Contney, Richard J Roman, et al.
Pageof 17